[1] Bouvard V, Baan R, Straif K, et al. A review of human carcinogens--Part B: biological agents [J]. Lancet Oncol, 2009,10(4):321-322. [2] Bruni L, Diaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings [J]. J Infect Dis, 2010,202(12):1789-1799.[3] Rositch AF, Koshiol J, Hudgens MG, et al. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis [J]. Int J Cancer, 2013,133(6):1271-1285.[4] Castle PE, Rodríguez AC, Burk RD, et al. Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer [J]. J Infect Dis, 2011,203(6):814-822. [5] Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia [J]. Vaccine, 2008,26 (Suppl 10):k1-16. [6] Ikenberg H. Laboratory diagnosis of human papillomavirus infection [J]. Curr Probl Dermatol, 2014,45:166-174.[7] Szarewski A, Mesher D, Cadman L, et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors study [J]. J Clin Microbiol, 2012,50(6):1867-1873.[8] Tao K, Yang J, Yang H, et al. Comparative study of the cervista and hybrid capture methods in detecting high-risk human papillomavirus in cervical lesions [J]. Diagn Cytopathol, 2014,42(3):213-217.[9] Laudadio J. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening [J]. Adv Anat Pathol,2013,20(3):158-167.[10] Stanley MA. Genital human papillomavirus infections: current and prospective therapies [J]. J Gen Virol, 2012,93(Pt 4):681-691.[11] Fathi R, Tsoukas MM. Genital warts and other HPV infections: established and novel therapies [J]. Clin Dermatol, 2014,32(2):299-306.[12] Massad LS, Einstein MH, Huh WK,et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors [J]. J Low Genit Tract Dis, 2013,17(5 Suppl 1):S1-S27.(2014-05-16收稿) |